Provexis (AQSE:PXS.GB) Days Payable : 87.69 (As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is Provexis Days Payable?

Provexis's average Accounts Payable for the six months ended in Sep. 2024 was £0.25 Mil. Provexis's Cost of Goods Sold for the six months ended in Sep. 2024 was £0.51 Mil. Hence, Provexis's Days Payable for the six months ended in Sep. 2024 was 87.69.

The historical rank and industry rank for Provexis's Days Payable or its related term are showing as below:

AQSE:PXS.GB' s Days Payable Range Over the Past 10 Years
Min: 14.44 Med: 212.3 Max: 1788.5
Current: 126.5

During the past 13 years, Provexis's highest Days Payable was 1788.50. The lowest was 14.44. And the median was 212.30.

AQSE:PXS.GB's Days Payable is ranked better than
68.59% of 936 companies
in the Drug Manufacturers industry
Industry Median: 87.555 vs AQSE:PXS.GB: 126.50

Provexis's Days Payable declined from Sep. 2023 (123.74) to Sep. 2024 (87.69). It may suggest that Provexis accelerated paying its suppliers.

Provexis Days Payable Historical Data

The historical data trend for Provexis's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Provexis Days Payable Chart

Provexis Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Payable

Get a 7-Day Free Trial

294.03

160.15

182.50

85.55

14.44

Provexis Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Days Payable	Get a 7-Day Free Trial															624.71	228.79	123.74	115.76	87.69

Competitive Comparison of Provexis's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Provexis's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Provexis's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Provexis's Days Payable distribution charts can be found below:

* The bar in red indicates where Provexis's Days Payable falls into.

Save Embed

;

Save Embed

;

Provexis Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Provexis's Days Payable for the fiscal year that ended in Mar. 2024 is calculated as

	Days Payable (A: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Mar. 2023 )	+	Accounts Payable (A: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2024 )	*	Days in Period
=	( (0.02	+	0.021)	/	2 )	/	0.518	*	365
=	0.0205					/	0.518	*	365
=	14.44

Provexis's Days Payable for the quarter that ended in Sep. 2024 is calculated as:

	Days Payable (Q: Sep. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Mar. 2024 )	+	Accounts Payable (Q: Sep. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
=	( (0.021	+	0.471)	/	2 )	/	0.512	*	365 / 2
=	0.246					/	0.512	*	365 / 2
=	87.69

Provexis Days Payable Related Terms

Thank you for viewing the detailed overview of Provexis's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Provexis Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Provexis PLC (AQSE:PXS.GB) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

PXS:UK

Address

2 Blagrave Street, I Ford, Reading, Berkshire, GBR, RG1 1AZ

Website

https://www.provexis.com

Provexis PLC is a British food company. It is engaged in developing and licensing the Fruitflow, which is patented, natural, breakthrough ingredient which helps with platelet aggregation. Fruitflow reduces the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can result in heart attack and stroke. The extract is available in two formats, a syrup and a powder, and it can be included in a broad range of food, beverage and dietary supplement formats.

Provexis Headlines

No Headlines